Brings
Relief - Safely
FDA-approved for GERD treatment. Heals severe erosive Esophagitis and reduces rebleeding effectively in bleeding peptic ulcer. Useful for treating hypersecretory conditions associated with neoplasia like ZES.
Effective relief with
short-course treatment
From healing severe erosive esophagitis to reducing rebleeding in peptic ulcers, and treating pathological hypersecretory conditions associated with neoplasia, FDA-labeled short-course treatment of GERD is a versatile alternative to oral therapy that offers effective relief for a range of gastrointestinal conditions.
- FDA labeled short-course treatment of GERD as an alternative to oral therapy (1)
- Heals severe erosive Esophagitis (2)
- Reduces rebleeding effectively in bleeding peptic ulcer (3)
- Useful in the treatment of pathological hypersecretory conditions associated with neoplasia such as ZES
1. American Product Monograph Rev 09/05 | 2. Dig Dis Sci 2008 June; 53(6): 1500-5 | 3. Digestion 2008;78(1):39-43
In Erosive Esophagitis, Peptic ulcer, Post operative
Suppression of acid
- Heals severe erosive Esophagitis
- Reduces rebleeding in peptic ulcer effectively
- FDA-approved treatment for GERD
